ZA992130B - Transdermal Therapeutic System. - Google Patents

Transdermal Therapeutic System.

Info

Publication number
ZA992130B
ZA992130B ZA9902130A ZA992130A ZA992130B ZA 992130 B ZA992130 B ZA 992130B ZA 9902130 A ZA9902130 A ZA 9902130A ZA 992130 A ZA992130 A ZA 992130A ZA 992130 B ZA992130 B ZA 992130B
Authority
ZA
South Africa
Prior art keywords
tts
oxybutynin
therapeutic system
transdermal therapeutic
matrix mass
Prior art date
Application number
ZA9902130A
Other languages
English (en)
Inventor
Christoph Arth
Dietrich W Schacht
Andreas Kollmeyer-Seeger
Stephan Rimpler
Hans-Michael Wolff
Original Assignee
Schwarz Pharma A G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schwarz Pharma A G filed Critical Schwarz Pharma A G
Publication of ZA992130B publication Critical patent/ZA992130B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
ZA9902130A 1998-03-20 1999-03-17 Transdermal Therapeutic System. ZA992130B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19812413A DE19812413C1 (de) 1998-03-20 1998-03-20 Transdermales Therapeutisches System (TTS) Oxybutynin enthaltend

Publications (1)

Publication Number Publication Date
ZA992130B true ZA992130B (en) 1999-09-17

Family

ID=7861773

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9902130A ZA992130B (en) 1998-03-20 1999-03-17 Transdermal Therapeutic System.

Country Status (19)

Country Link
US (1) US6555129B1 (xx)
EP (1) EP1063983B1 (xx)
JP (1) JP2002507565A (xx)
KR (1) KR100561961B1 (xx)
CN (1) CN1134254C (xx)
AT (1) ATE209912T1 (xx)
AU (1) AU745923B2 (xx)
BR (1) BR9908910A (xx)
CA (1) CA2311354C (xx)
DE (3) DE19812413C1 (xx)
DK (1) DK1063983T3 (xx)
ES (1) ES2165232T3 (xx)
HK (1) HK1035864A1 (xx)
IL (1) IL135306A (xx)
MX (1) MXPA00009231A (xx)
NZ (1) NZ504038A (xx)
PT (1) PT1063983E (xx)
WO (1) WO1999048493A1 (xx)
ZA (1) ZA992130B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US7029694B2 (en) 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
CN101305994A (zh) * 2000-04-26 2008-11-19 沃特森药物公司 最小化与奥昔布宁疗法有关的副作用
DE10033855A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Matrixkontrolliertes transdermales System mit Sulfonsäuresalz eines ACE-Hemmers
DE10060550C1 (de) * 2000-12-06 2002-04-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
US20050058688A1 (en) * 2003-02-22 2005-03-17 Lars Boerger Device for the treatment and prevention of disease, and methods related thereto
DE10315878B4 (de) * 2003-04-08 2009-06-04 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Fesoterodin und Verwendung
TW200512013A (en) * 2003-09-18 2005-04-01 Orient Europharma Co Ltd Gel formulation of oxybutynin hydrochloride
CN102309447A (zh) * 2010-07-06 2012-01-11 上海现代药物制剂工程研究中心有限公司 含盐酸奥昔布宁的自粘性喷雾透皮组合物及制备方法
WO2012089256A1 (en) * 2010-12-29 2012-07-05 Pharmafilm S.R.L. Medicated patch for improved transdermal permeation of diclofenac diethylammonium
CN103919754B (zh) * 2013-01-15 2018-11-06 江苏康倍得药业股份有限公司 奥昔布宁药物组合物及其应用
US10149828B2 (en) 2015-01-09 2018-12-11 Chase Pharmaceuticals Corporation Oxybutynin transdermal therapeutic system combination
CN108498491A (zh) * 2018-06-26 2018-09-07 沈阳药科大学 一种奥昔布宁经皮吸收贴剂及其制备和应用
CN113143891B (zh) * 2021-04-27 2022-05-03 杭州仁德医药有限公司 一种奥昔布宁透皮贴膏及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6139868A (en) * 1986-08-28 2000-10-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
JP3136413B2 (ja) * 1991-02-22 2001-02-19 リードケミカル株式会社 経皮吸収型頻尿・尿失禁治療剤
DE4310012A1 (de) 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
CA2165802A1 (en) * 1993-09-29 1995-04-06 Eun Soo Lee Monoglyceride/lactate ester permeation enhancer for oxybutynin
US5601839A (en) * 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
PT889723E (pt) * 1996-03-25 2002-11-29 Lohmann Therapie Syst Lts Sistema terapeutico transdermico com pequena espressura da zona de aplicacao e elevada flexibilidade assim como processo de producao
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher

Also Published As

Publication number Publication date
HK1035864A1 (en) 2001-12-14
JP2002507565A (ja) 2002-03-12
DK1063983T3 (da) 2002-01-07
EP1063983A1 (de) 2001-01-03
IL135306A (en) 2005-06-19
PT1063983E (pt) 2002-05-31
MXPA00009231A (es) 2002-06-04
EP1063983B1 (de) 2001-12-05
NZ504038A (en) 2001-09-28
CA2311354C (en) 2004-08-10
US6555129B1 (en) 2003-04-29
CN1288376A (zh) 2001-03-21
WO1999048493A1 (de) 1999-09-30
DE29823343U1 (de) 1999-07-15
BR9908910A (pt) 2000-11-21
IL135306A0 (en) 2001-05-20
DE59900497D1 (de) 2002-01-17
CA2311354A1 (en) 1999-09-30
KR100561961B1 (ko) 2006-03-21
ES2165232T3 (es) 2002-03-01
AU745923B2 (en) 2002-04-11
AU3145299A (en) 1999-10-18
ATE209912T1 (de) 2001-12-15
KR20010031668A (ko) 2001-04-16
DE19812413C1 (de) 1999-06-10
CN1134254C (zh) 2004-01-14

Similar Documents

Publication Publication Date Title
HK1047703A1 (zh) 含有托特羅定的經皮治療系統(tts)
HK1035864A1 (en) Transdermal therapeutic system (tts) containing oxybutynin.
AU743229C (en) Transdermal therapeutic system containing pergolide
NZ306249A (en) matrix patch containing triacetin as a transdermal pentration enhancer
NO883591L (no) Dermal administrasjonsform.
CA2153572A1 (en) Transdermal therapeutic system with galanthamine as active ingredient
DE59308413D1 (de) Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung
DE59807891D1 (de) Transdermales therapeutisches system (tts) enthaltend ammoniogruppenhaltige (meth)acrylatpolymere zur verabreichung von levonorgestrel
DE50212267D1 (de) Transdermales therapeutisches system für die verabreichung carboxylgruppenhaltiger, nichtsteroidaler antiphlogistika, sowie verfahren zu seiner herstellung
DK1383540T3 (da) Fremgangsmdåer og farmaceutiske sammensætninger til sårheling
CA2251966A1 (en) Transdermally administered dextromethorphan as antitussive agent
MD937C2 (ro) Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui
MD348C2 (ro) Sistem terapeutic transdermal şi procedeu de obţinere a acestuia